J&J bought out Verily, Alphabet’s life sciences unit, and the deal is expected to close in the first half of next year.
J&J and Verily created Verb as a way to combine J&J’s capabilities in surgery and advanced instrumentation with Alphabet’s expertise in machine learning and data analytics to build robot-assisted interventions for use in open surgery, according to MedTech Dive.
To date, J&J has reportedly spent about $12 billion on mergers and acquisitions in the medical device industry “to make sure we’re playing in the most attractive spaces,” Ashley McEvoy, head of J&J’s medical devices unit, told MedTech Dive.
Read the full article here.
More articles on supply chain:
Boston Scientific not allowed to cancel Channel Medsystems acquisition, court rules
Stericycle cancels plans to open North Las Vegas facility
Amazon’s block of FedEx shipping option reportedly linked to late deliveries
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
